Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial
Article in ESMO Open (February 2024)
The most recent citing publications are shown below. View all 84 publications that cite this research output on Dimensions.
Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer.
Article in Journal of Environmental Pathology Toxicology and Oncology (January 2024)
Non-Small Cell Lung Cancer: Targetable Variants in Concurrent Tissue and Liquid Biopsy Testing in a North Indian Cohort
Article in Asian Pacific Journal of Cancer Prevention (October 2023)